4.6 Article

High-throughput analysis of the activities of xCas9, SpCas9-NG and SpCas9 at matched and mismatched target sequences in human cells

Journal

NATURE BIOMEDICAL ENGINEERING
Volume 4, Issue 1, Pages 111-124

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/s41551-019-0505-1

Keywords

-

Funding

  1. National Research Foundation of Korea [2017R1A2B3004198, 2017M3A9B4062403, 2018R1A5A2025079]
  2. Brain Korea 21 Plus Project (Yonsei University College of Medicine), Institute for Basic Science (IBS) [IBS-R026-D1]
  3. Yonsei University Future-leading Research Initiative of 2015 [RMS2 2015-22-0092]
  4. Korean Health Technology R&D Project, Ministry of Health and Welfare of the Republic of Korea [HI17C0676, HI16C1012]
  5. US NIH [RM1 HG009490, R01 EB022376, R35 GM118062]
  6. HHMI
  7. National Research Foundation of Korea [IBS-R026-D1-2020-A00] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

Ask authors/readers for more resources

A comparison of compatibilities in protospacer adjacent motifs and of on-target and off-target activities of Streptococcus pyogenes Cas9 variants at endogenous sites in human cells enables the editing of new genomic sites associated with genetic diseases. The applications of clustered regularly interspaced short palindromic repeats (CRISPR)-based genome editing can be limited by a lack of compatible protospacer adjacent motifs (PAMs), insufficient on-target activity and off-target effects. Here, we report an extensive comparison of the PAM-sequence compatibilities and the on-target and off-target activities of Cas9 from Streptococcus pyogenes (SpCas9) and the SpCas9 variants xCas9 and SpCas9-NG (which are known to have broader PAM compatibility than SpCas9) at 26,478 lentivirally integrated target sequences and 78 endogenous target sites in human cells. We found that xCas9 has the lowest tolerance for mismatched target sequences and that SpCas9-NG has the broadest PAM compatibility. We also show, on the basis of newly identified non-NGG PAM sequences, that SpCas9-NG and SpCas9 can edit six previously unedited endogenous sites associated with genetic diseases. Moreover, we provide deep-learning models that predict the activities of xCas9 and SpCas9-NG at the target sequences. The resulting deeper understanding of the activities of xCas9, SpCas9-NG and SpCas9 in human cells should facilitate their use.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available